Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMXDLUH)

Drug Name

NGD-4715 Drug Info

Synonyms

NGD-4715; 476322-70-0; 1-(5-bromo-6-methoxypyridin-2-yl)-4-(3,4-dimethoxybenzyl)piperazine; SCHEMBL4712990; DTXSID10432090; VAKYVNYLCIABRV-UHFFFAOYSA-N; HY-100318

Indication

Disease Entry	ICD 11	Status	REF
Obesity	5B81	Discontinued in Phase 1	[1]

Cross-matching ID

PubChem CID: 9866893
CAS Number: CAS 476322-70-0
TTD Drug ID: DMXDLUH

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting Melanin-concentrating hormone receptor 1 (MCHR1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
BMS-830216	DMCW71N	Obesity	5B81	Phase 1	[3]
AZD1979	DMQ1OX4	Obesity	5B81	Phase 1	[4]
PMID25522065-Compound-27	DMXN4KB	N. A.	N. A.	Patented	[5]
PMID25522065-Compound-29	DMBNAK9	N. A.	N. A.	Patented	[5]
PMID25522065-Compound-34	DMZDIRQ	N. A.	N. A.	Patented	[5]
PMID25522065-Compound-39	DM5YMQH	N. A.	N. A.	Patented	[5]
PMID25522065-Compound-40	DMCIQ01	N. A.	N. A.	Patented	[5]
PMID25522065-Compound-11	DM410Z6	N. A.	N. A.	Patented	[5]
PMID25522065-Compound-50	DMBWA0V	N. A.	N. A.	Patented	[5]
PMID25522065-Compound-12	DMVKO9C	N. A.	N. A.	Patented	[5]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Melanin-concentrating hormone receptor 1 (MCHR1)	TTX4RTB	MCHR1_HUMAN	Antagonist	[2]

------------------------------------------------------------------------------------

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025311)
2	CenterWatch. Drugs in Clinical Trials Database. CenterWatch. 2008.
3	2011 Pipeline of Bristol-Myers Squibb.
4	Phase I clinical trial of AZD1979 for treating obesity. AstraZeneca plc
5	Novel MCH1 receptor antagonists: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):193-207.